Pi-Cardia

Unique Non-Implant Based Valve Treatments | Pi-Cardia | Israel

Business Model
B2B
Last Round
Series BApr 2020
Rounds
3

About

Pi-Cardia is a global leader in the development of a unique portfolio of non-implant, catheter-based, leaflet modification solutions for treating heart valves. Its ShortCut™ device splits valve leaflets of a pre-existing valve prior to TAVR to reduce risk of coronary obstruction, while its Leaflex™ device mechanically scores valve calcification to restore leaflet flexibility and improve valve hemodynamics in patients with calcified aortic stenosis.

Summary

Pi-Cardia is a Medtech company based in Israel. Its most recent funding was a Series B round in Apr 2020.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2020

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pi-Cardia on Indexed.vc
<a href="https://indexed.vc/companies/pi-cardia"><img src="https://indexed.vc/api/badge/company/pi-cardia" alt="Pi-Cardia on Indexed.vc" width="260" height="76" /></a>